Relations between dairy food intake and arterial stiffness: Pulse wave velocity and pulse pressure by Crichton, Georgina E. et al.
The University of Maine
DigitalCommons@UMaine
Maine-Syracuse Longitudinal Papers Maine-Syracuse Longitudinal Study
2012
Relations between dairy food intake and arterial
stiffness: Pulse wave velocity and pulse pressure
Georgina E. Crichton
University of South Australia
Merrill F. Elias
University of Maine, mfelias@maine.edu
Gregory A. Dore
University of Maine
Walter P. Abhayaratna
Michael A. Robbins
University of Maine, michael.robbins@umit.maine.edu
Follow this and additional works at: https://digitalcommons.library.umaine.edu/
longitudinal_papers
This Article is brought to you for free and open access by DigitalCommons@UMaine. It has been accepted for inclusion in Maine-Syracuse
Longitudinal Papers by an authorized administrator of DigitalCommons@UMaine. For more information, please contact
um.library.technical.services@maine.edu.
Repository Citation
Crichton, Georgina E.; Elias, Merrill F.; Dore, Gregory A.; Abhayaratna, Walter P.; and Robbins, Michael A., "Relations between dairy
food intake and arterial stiffness: Pulse wave velocity and pulse pressure" (2012). Maine-Syracuse Longitudinal Papers. 41.
https://digitalcommons.library.umaine.edu/longitudinal_papers/41
Arterial Stiffness
Relations Between Dairy Food Intake and Arterial Stiffness
Pulse Wave Velocity and Pulse Pressure
Georgina E. Crichton, Merrrill F. Elias, Gregory A. Dore, Walter P. Abhayaratna, Michael A. Robbins
Abstract—Modifiable risk factors, such as diet, are becomingly increasingly important in the management of cardiovas-
cular disease, one of the greatest major causes of death and disease burden. Few studies have examined the role of diet
as a possible means of reducing arterial stiffness, as measured by pulse wave velocity, an independent predictor of
cardiovascular events and all-cause mortality. The aim of this study was to investigate whether dairy food intake is
associated with measures of arterial stiffness, including carotid-femoral pulse wave velocity and pulse pressure. A
cross-sectional analysis of a subset of the Maine-Syracuse Longitudinal Study sample was performed. A linear decrease
in pulse wave velocity was observed across increasing intakes of dairy food consumption (ranging from never/rarely to
daily dairy food intake). The negative linear relationship between pulse wave velocity and intake of dairy food was
independent of demographic variables, other cardiovascular disease risk factors, and nutrition variables. The pattern of
results was very similar for pulse pressure, whereas no association between dairy food intake and lipid levels was found.
Further intervention studies are needed to ascertain whether dairy food intake may be an appropriate dietary intervention
for the attenuation of age-related arterial stiffening and reduction of cardiovascular disease risk. (Hypertension. 2012;
59:1044-1051.) ● Online Data Supplement
Key Words: pulse wave velocity  arterial stiffness  blood pressure  dairy food
Cardiovascular disease (CVD) is one of the leading causesof death and disease burden in Europe, the United States,
and Australia. As populations age, the risk, prevalence and
cost of CVD are likely to further increase. Positive modifiable
risk factors for CVD, including diet, will become increasingly
important to alter the course of this disease.
Dairy foods and milk products have received a negative
reaction in the media in the recent past, largely because of the
association between saturated fatty acids and CVD risk and
the high saturated fatty acid content in dairy foods. However,
a number of recent reviews of milk and dairy consumption
and CVD have concluded that dairy foods are not associated
with a higher risk of CVD and, indeed, may offer some
benefit. The Dietary Approaches to Stop Hypertension
(DASH) Study was one of the first studies to show that a diet
high in low-fat dairy can have beneficial effects on blood
pressure (BP).1 Following the DASH diet, high in fruit,
vegetables, and low-fat dairy products (3 serves per day),
for 6 months was associated with greater reduction in systolic
BP (SBP) and diastolic BP (DBP) than either a control diet or
a weight-reducing diet, among men and women. These
reductions were in the range of 11 to 12 mm Hg for SBP and
6 to 7 mm Hg for DBP.1 Although the individual contribu-
tions of low-fat dairy on BP could not be determined from
this combination diet, the DASH Study researchers attributed
the beneficial BP effect to the high intake of dairy-rich
calcium and potassium in the DASH Study diet. Evidence
with respect to consumption of milk and dairy products in
relation to BP reduction has been summarized in a recent
review of the literature.2 Based on results from 11 cross-
sectional and 8 prospective studies, it was concluded that
increased dairy food consumption is associated with lower
SBP and lower risk for hypertension, particularly for low-fat
dairy food. A recent intervention study has also demonstrated
a reduction in SBP after an intake of 3 servings of low-fat
dairy products per day for 2 months.3
Traditionally, BP is measured by assessing the pressure in
the brachial artery in the upper arm, and arterial stiffness is
assessed by way of pulse pressure (PP; SBPDBP). However
it is becoming increasingly recognized that measures of
central arterial function, that is, measures of arterial stiffness,
are more valuable predictors of vascular health outcomes.4
The central arteries slowly stiffen with age, with the rate
influenced by hypertension, diabetes mellitus, and atheroscle-
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rosis.5 Pulse wave velocity (PWV) is now considered the gold
standard noninvasive method for measuring arterial stiffness
and is an independent predictor of cardiovascular events and
all-cause mortality.6,7
There have been few studies on the role of micronutrients
in the treatment of arterial stiffness. A recent review showed
support for the intake of omega 3 fish oils and soy isofla-
vones, as well as consumption of fermented milk products
containing bioactive peptides.8 Studies evaluating the rela-
tionship between milk and dairy products and holistic mark-
ers of CVD risk, such as arterial stiffness, have been
recommended,9 as has research to examine the role of
micronutrients in the treatment of arterial stiffness.8 The aim
of our study was to examine dairy food intake, per se, in
relation to measures of arterial stiffness via carotid-femoral
PWV (cfPWV), PP, and other indices of cardiovascular
health, including SBP and DBP.
Methods
Participants
Participants were obtained from the Maine-Syracuse Longitudinal
Study (MSLS), a study designed to examine cardiovascular risk
factors in relation to cognitive performance in community-dwelling
individuals. The MSLS consists of 5 cohorts defined by time of entry
into the study (1975–2000). Recruitment and data collection proce-
dures for the MSLS have been described previously in detail.10 The
data for the present study were obtained from those participants
returning for the seventh study wave, because both cfPWV and
dietary intake measures were obtained at this examination for the
first time.
From an initial sample of 626 individuals with cfPWV data at
wave 7, participants were excluded in the following order: (1) history
of stroke (n14); (2) probable dementia (n2); (3) inability to read
English (n1); (4) missing data on dairy consumption (n3); or (5)
suboptimal quality of data on arterial stiffness as defined a priori as
a cfPWV error of estimate20% (n19). Dementia and stroke were
reasons for exclusion, because we were interested in examining rela-
tionships between diet and arterial stiffness in a community-dwelling,
relatively healthy study population. The characteristics of the final
sample with complete data (N587) are presented in Table 1.
The University of Maine Institutional Review Board approved this
study, and the use of deidentified MSLS data was approved by the
University of South Australia Human Ethics Committee. All of the
participants provided informed consent for data collection, and all of
the procedures followed were in accordance with institutional
guidelines.
Procedure
Within 2 weeks of the laboratory visit, participants completed the
Center for Epidemiological Studies Depression Scale (CES-D),11 the
Nurses’ Health Study Activity Questionnaire,12 and the Nutrition
and Health Questionnaire.13 At this visit, a blood sample, brachial
artery BP, and pulse wave measures were obtained before breakfast,
after an overnight fast. Standard assay methods were used10,14 to
obtain total cholesterol, high-density lipoprotein (HDL) cholesterol,
low-density lipoprotein (LDL) cholesterol, triglycerides, fasting
plasma glucose, and plasma homocysteine. After a light breakfast,
including decaffeinated tea or coffee, participants underwent a
medical interview, including a detailed medical history.
BP and cfPWV Assessment
Brachial artery pressures were measured in accordance with the
procedure at previous MSLS waves, taken 5 times each in reclining,
sitting, and standing positions after a supine rest for 10 minutes, with
a 5-minute rest between each set of measures. Measures were taken
using the traditional pressure-cuff method (Critikon Dinamap Pro-
Care 100, oscillometric method).
In a supine position, cfPWV was assessed noninvasively using the
SphygmoCor system (AtCor Medical) with applanation tonometry.
The carotid-femoral path length was estimated as the surface
distances joining the suprasternal notch, the umbilicus, and the
femoral pulse subtracted from distance between the suprasternal
notch and the carotid pulse. Carotid-femoral transit time was
estimated in 8 to 10 sequential ECG-gated femoral and carotid
waveforms as the average time difference between the onset of the
femoral and carotid waveforms. The intersecting tangent method was
used to identify the foot of the pulse wave. PWV was calculated as
the carotid-femoral path length divided by the carotid-femoral transit
time, a reproducible measure of central arterial stiffness.6
Dietary Assessment
Diet was assessed using the Nutrition and Health Questionnaire,
which is composed of 41 questions about dietary intake, smoking
history, physical activity, marital status, medical history, self-
reported health, and medication and supplement use.13,15 The ques-
tionnaire has been used in a large investigation of cancer and
nutrition, and its acceptable validity has been demonstrated by
comparison with dietary recall, protein excretion, and total energy
expenditure data.16 The dietary component questions participants
about their frequency of consumption of meat, fish, dairy products,
eggs, breads, cereals, and beverages including tea, coffee, carbonated
drinks, water, fruit juice, and alcohol. A comprehensive list of 37
foods follows, and participants are required to stipulate how fre-
Table 1. Self-Reported Intakes of Cheese, Yoghurt/Dairy Desserts, Cream/Ice Cream, Total Dairy Food, and Milk (N587)
Dairy Product
Dairy Food Intake
Never/Seldom,
n (%)
1 Time per wk,
n (%)
2–4 Times
per wk, n (%)
5–6 Times
per wk, n (%)
1 Time
per d, n (%)
Cheese 92 (15.7) 147 (25.0) 245 (41.8) 70 (11.9) 33 (5.6)
Yoghurt and dairy desserts 275 (46.8) 98 (16.7) 130 (22.1) 44 (7.5) 40 (6.8)
Cream and ice cream 294 (50.1) 164 (28.0) 100 (17.0) 21 (3.6) 8 (1.4)
Total dairy food 37 (6.3) 40 (6.8) 141 (24.0) 153 (26.1) 216 (36.8)
0–150 mL/d 150 mL/d 300 mL/d 450 mL/d 600 mL/d
Milk 180 (30.7) 67 (11.4) 151 (25.7) 32 (5.5) 157 (26.7)
Whole fat (5.9%)* 13 (40.6) 3 (9.4) 6 (18.8) 1 (3.1) 7 (21.9)
Skim/reduced fat (80.4%)* 126 (28.7) 53 (12.1) 103 (23.5) 27 (6.2) 124 (28.3)
Other (eg, soy; 13.7%)* 28 (37.3) 7 (9.3) 12 (16.0) 3 (4.0) 23 (30.7)
*Percentage from within-milk group.
Crichton et al Dairy Food and Arterial Stiffness 1045
 by guest on June 9, 2017
http://hyper.ahajournals.org/
D
ow
nloaded from
 
quently they consume each food, with 6 response options: never,
seldom, once a week, 2 to 4 times a week, 5 to 6 times a week, or
once or more a day. These 6 response options were used to form the
5-level categorization of total dairy food consumption, with the
never and seldom respondents grouped together because of the low
numbers in each category. Dairy products included were milk,
cheese, yoghurt and dairy desserts (grouped together), ice cream and
cream (grouped together), and total dairy foods. Milk was the only
dairy food for which participants were asked to stipulate the fat
content of milk consumed (whole fat, reduced fat, or skim). Milk
intake included milk on cereal and in other beverages, such as tea
and coffee. Soy milk intake was not included in any analyses of dairy
and cfPWV.
The median score within each response option was used to
estimate total intakes per week for each food in the questionnaire; for
example, 2 to 3 times per week was estimated at 2.5. These totals
were used to determine mean daily intakes for each food. Because
portion sizes were not stipulated, the totals are an estimate of the
number of times each food was consumed on a daily basis.
Individual foods were grouped into 5 major food categories (in
addition to dairy products), grains, fruits, vegetables, protein foods,
and fats/sweets/other (empty calories), based on the US Department
of Agriculture MyPlate.17 Intakes of individual foods and beverages
within each food group were summed to give an estimate of total
intake for each group, and intakes for all of the food groups were
added to estimate total energy intake. The primary predictor variable
in this study was the 5-level categorization of total dairy food
consumption.
Covariates
Variables that were measured at the physical examination and were
considered as candidates for inclusion in the covariate sets included
height, weight, body mass index (BMI), waist circumference, and
prevalent obesity, diabetes mellitus, hypertension, and CVD. BMI
was calculated from height and weight (in kilograms per meter
squared), and obesity was defined as BMI of 30 kg/m2. Waist
circumference was measured over light clothing, using a nonextend-
able tape at the level of the iliac crest. Diabetes mellitus was defined
as treatment with insulin, oral antidiabetic agents, or by fasting
glucose level of 7 mmol/L. Hypertension was defined as treatment
for hypertension or a BP of 140/90 mm Hg. Prevalent CVD was
defined by the self-reported presence of coronary artery disease,
myocardial infarction, congestive heart failure, transient ischemic
attack, or angina pectoris and confirmed by medical charts. Where
necessary, diagnostic determinations were confirmed by chart review
with permission.
Statistical Analyses
Data were analyzed with SPSS (version 18; SPSS, Chicago, IL).
Preliminary analyses were performed to assess any significant
correlations among dairy intake, cfPWV, and other demographic,
health, nutrition, and lifestyle factors. The dairy intakes in the sample
were calculated, and the demographic, health, and dietary character-
istics of those who consume dairy food at least once per day and
those who consume less than this were tested for differences using
ANOVA or 2 tests where appropriate. For the primary analyses,
univariate ANCOVA was used to compare cfPWV across increasing
intakes of dairy food consumption, ranging from never/seldom to at
least once per day, and polynomial trend analyses were performed
across the 5 levels of dairy food intake only after the ANCOVA test
of the dairy intake main effect was found to be statistically
significant (P0.05). If the omnibus test of overall differences
among groups was observed, any significant trends were reported.
Adjustments for multiple comparisons among dairy food intake
groups were made and reported in terms of the Bonferroni
adjustment.
An age-adjusted model was first performed, and then analyses
followed using 4 covariate sets. The extended covariate sets were as
follows: (1) basic covariate set: age, sex, education, and race; (2)
extended covariate set 1: basic setheight, weight, heart rate,
antihypertensive drug treatment (yes/no), and mean arterial pressure
(MAP); (3) extended covariate set 2: extended covariate set 1waist
circumference, total cholesterol, HDL, and LDL cholesterol; and (4)
extended covariate set 3: extended covariate set 2depressive
symptoms (CES-D raw score), intake of grains, vegetables, protein
foods, empty calories (sweets, fats, and others), and total intake from
all of the food groups (all in times per day).
Because adjustment for height when assessing cfPWV has been
recommended,18 height and weight were used in the extended
covariate set 1 instead of BMI. However, alternative analyses
(reported in the Results section) were done with height and weight
removed and with waist circumference substituted.
Variables were required to meet 1 of 2 criteria to be included as an
additional covariate: significantly related (P0.05) to dairy food
intake (the predictor) and cfPWV (the primary outcome variable) to
be included in the second extended model or differed significantly
between low (less than once per day) and high (at least daily) dairy
consumers to be included in the third extended model. Preliminary
correlational analyses were performed to ensure that MAP had the
same relationship to cfPWV in each dairy intake category. MAP was
calculated as DBP1/3(SBPDBP). cfPWV was significantly cor-
related with MAP for both low dairy consumers (1 time per day,
n371) and high dairy consumers (1 time per day, n216),
indicating that MAP has the same relationship to PWV regardless of
dairy intake. Additional analyses were performed with the inclusion
of a dairy intakeMAP interaction term.
Supplemental Table 1 shows those health and dietary variables
that were significantly correlated with both dairy food intake and
cfPWV. Although PWV, SBP, and PP were highly correlated, they
were used as dependent variables in the current study. For all of the
models used, covariates were entered simultaneously with the
predictor variables.
Results
The self-reported intakes of dairy foods (milk, cheese, yo-
ghurt and dairy desserts, and cream and ice cream) are shown
in Table 1. Slightly more than one third of the sample (36.8%)
reported eating dairy food at least once per day. Half of
participants (50.1%) reported eating dairy foods between 2
and 6 times per week. The remaining participants (13.1%)
reported eating dairy foods no more than once per week. For
individual foods, milk was the dairy product consumed most
frequently on a daily basis. Nearly one third of the sample
reported drinking 600 mL of milk per day, equating to just
over 2 servings per day. A similar proportion of the sample
consumed 150 mL per day, with the remaining participants
(42.6%) drinking between 150 and 450 mL per day. Of those
that drank milk, the majority reported drinking skim or
reduced fat milk (80.4%). Cheese was most often consumed
between 2 and 4 times per week. Yoghurt, dairy desserts,
cream, and ice cream were consumed infrequently.
In Table 2, the demographic, health, and nutritional char-
acteristics of participants who consumed dairy food at least
daily (36.8%) are compared with those who consumed dairy
food less frequently than this (63.2%). Participants who
consumed dairy on a daily basis consumed more vegetables
and protein foods but fewer grains and empty calories
(sweets/fats), adjusting for total energy intake, compared with
those who ate dairy less frequently than this. They also had a
higher number of years of education, lower body weight and
waist circumference, lower SBP and DBP, and fewer depres-
sive symptoms (all P0.05). More women than men con-
sumed dairy food on a daily basis.
There was a decrease in cfPWV, PP, and SBP for partic-
ipants across increasing intakes of dairy food, ranging from
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Table 2. Demographic Variables, Health Characteristics, and Dietary Intake of Sample, Comparing Those
Who Consume Dairy Food at Least Once per Day Compared With Less Than This (N587)
Demographic/Health Characteristic
Dairy Food 1
Time/Day (n371)
Dairy Food at Least 1
Time/Day (n216)
P*Mean SD Mean SD
Age, y 63.0 12.7 65.2 11.6 0.039
Education, y 14.4 2.7 15.0 2.9 0.019
Physical activity, MET hours/wk 21.2 27.9 24.6 26.2 NS
Smoking, cigarettes per wk 9.3 36.8 5.5 32.2 NS
Waist circumference, cm 95.1 15.1 91.8 16.5 0.015
Weight, kg 84.3 19.6 80.8 18.7 0.035
BMI, kg/m2 29.9 6.8 29.1 6.0 NS
cfPWV, m/s 10.4 2.9 10.1 2.7 NS
SBP, mm Hg 130.9 20.6 126.8 18.6 0.016
DBP, mm Hg 78.2 10.2 75.8 9.5 0.005
MAP, mm Hg 95.8 12.4 92.8 11.3 0.004
PP, mm Hg 52.7 16.2 51.0 14.7 NS
Heart rate, bpm 60.2 9.6 59.9 8.9 NS
Total cholesterol, mmol/L 4.8 1.0 4.9 1.0 NS
HDL cholesterol, mmol/L 1.4 0.4 1.4 0.4 NS
LDL cholesterol, mmol/L 2.9 0.8 2.9 0.8 NS
Triglycerides, mmol/L 1.3 0.9 1.3 0.8 NS
Glucose, mmol/L 5.5 1.4 5.4 1.2 NS
Depression, CES-D§ 8.6 7.6 7.1 7.4 0.017
n
% (Within 1 Time
per d Group) n
% (Within 1 Time
per d Group) P†
Sex
Males 154 41.5 70 32.4 0.029
Females 217 58.5 146 67.6 0.029
Race
White 301 81.1 203 94.0 0.001
Other 70 18.9 13 6.0 0.001
CVD 41 11.1 29 13.4 NS
Diabetes mellitus 57 15.4 30 13.9 NS
Hypertension 238 64.2 122 56.5 NS
Antihypertensive medication 204 55.0 113 52.3 NS
Cholesterol-lowering medication 130 35.0 74 34.3 NS
Diabetes mellitus medication 50 13.5 29 13.4 NS
Mean SEM Mean SEM P‡
Grains per d 3.5 0.08 3.2 0.10 0.010
Fruits per d 1.5 0.05 1.6 0.07 NS
Vegetables per d 2.6 0.05 2.9 0.07 0.002
Protein foods per d 1.8 0.04 1.9 0.05 0.024
Other (fats/sweets) per d 2.1 0.08 1.5 0.11 0.001
Alcohol, standard drinks per d 0.4 0.04 0.4 0.05 NS
Total all foods served per d¶ 12.0 3.8 13.5 4.1 0.001
BMI indicates body mass index; CES-D, Centre for Epidemiologic Studies Depression Scale; cfPWV, carotid-femoral pulse wave
velocity; CVD, cardiovascular disease; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MAP,
mean arterial pressure; MET, metabolic equivalent; PP, pulse pressure; SBP, systolic blood pressure.
*Data show ANOVA for continuous variables.
†Data show 2 for categorical variables.
‡Data show ANCOVA, controlling for total servings per day for all of the food groups.
§For CES-D, higher score indicates greater number of depressive symptoms.
CVD was defined as present if there was self-reported history of coronary artery disease, myocardial infarction, congestive heart
failure, transient ischemic attack, or angina pectoris.
¶Mean and SD, includes alcohol.
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never/seldom to1 time per day (Table 3). Table 3 shows the
95% confidence limits associated with each mean for each
group and summarizes the results of statistical analyses for
the age-adjusted, basic, and the most extended models. Table
S2 describes the results for each covariate set for each
dependent variable.
For the age-adjusted model, the lowest cfPWV values
(mean value: 9.9 m/s) were observed for those who consumed
dairy products5 to 6 times per week and daily (mean value:
10.0 m/s). With the addition of demographic variables, other
cardiovascular risk factors, and nutrition variables, this sig-
nificant linear trend across increasing intakes of dairy food
remained (extended covariate set 3). The cfPWV of those in
the lowest 3 intake categories (eat dairy 0–4 times per week)
was significantly higher than the cfPWV for those in the
highest 2 intake categories (eat dairy 5–7 times per week;
P0.001). No associations between individual dairy foods
(milk, cheese, yoghurt and dairy desserts, and cream and ice
cream) and cfPWV were found (all P0.30).
The pattern of results was very similar for PP and SBP
(Table 3). For all of the fully extended models, PP and SBP
decreased in a linear fashion as dairy food intake increased.
Contrasts performed between categories of intake showed
that those who consumed dairy food 5 to 6 times per week
had significantly lower PP and SBP than those who never or
rarely consumed dairy foods, after adjustment for demo-
graphic, cardiovascular, and dietary factors. Figure S1 shows
the reductions in cfPWV, PP, and SBP across increasing
intakes of dairy food.
No significant differences among dairy intake groups were
observed for DBP, waist circumference, total cholesterol,
HDL and LDL cholesterol, or triglyceride measures for either
the basic or extended models. These results are displayed in
the supplemental data (Table S2).
Additional Analyses
The pattern of significant results remain unchanged when the
following additional regression models were used: waist
circumference was substituted for height and weight, a
MAPdairy intake interaction was used in the model with
MAP, and physical activity was added to the extended
covariate sets. The analyses were repeated for participants not
on any medication (n218). Comparing those who ate dairy
less than daily (n137) with those who ate dairy food at least
daily (n81), the patterns of results for cfPWV were the
same as for the whole sample, with the high dairy consumers
having a lower cfPWV in all of the covariate models (data not
shown).
Discussion
Dairy product intake was inversely associated with cfPWV
and SBP, with adjustment for demographic, cardiovascular,
and dietary factors. cfPWV, PP, and SBP all decreased in a
linear fashion as dairy food intake increased across categories
of intake from never/seldom to 5 to 6 times per week or more.
Importantly, we have also shown that dairy food intake is not
adversely associated with higher levels of cholesterol (total,
HDL, and LDL cholesterol) or increased abdominal obesity
(as measured by waist circumference). Moreover, our results
for cfPWV, the gold standard measure of arterial stiffness,
were supported by our findings for PP and SBP, surrogate
hemodynamic indices of arterial stiffness.
Table 3. Results of ANCOVA, Showing Associations Among cfPWV, PP, and SBP Across Increasing Intakes of Dairy Food (N587),
for Basic, Age-Adjusted, and Extended Covariate Set 3
Outcome
Measure Covariate Set
Dairy Food Intake
P*
Never/Seldom
(n37)
1 Time per wk
(n40)
2–4 Times
per wk (n141)
5–6 Times
per wk (n153) 1 Time per d (n216)
Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI
cfPWV Age-adjusted 10.8 10.0–11.5 11.1 10.4–11.8 10.8 10.4–11.2 9.9¶ 9.6–10.3 10.0¶ 9.7–10.3 .000‡
Basic 10.6 9.8–11.4 10.9 10.2–11.6 10.7 10.3–11.1 10.0 9.6–10.3 10.1 9.7–10.4 .016†
Extended 3 11.0 10.3–11.7 10.8 10.1–11.5 10.6 10.3–11.0 10.0 9.6–10.3 10.1 9.8–10.4 .018‡
PP Age-adjusted 56.3 51.9–60.7 57.8 53.5–62.1 53.2 50.9–55.5 51.3 49.1–53.4 50.2 48.3–52.0 .003‡
Basic 56.3 51.9–60.6 56.6 52.3–60.9 52.7§ 50.5–55.0 51.4§ 49.2–53.5 50.6§ 48.8–52.4 .035‡
Extended 3 57.6 54.1–61.0 53.1 49.8–56.5 52.4 50.6–54.1 50.8§ 49.2–52.4 51.6§ 50.2–53.0 .013‡
SBP Age-adjusted 131.8 125.6–137.9 138.7 132.7–144.6 131.7 128.5–134.8 128.8 125.8–131.9 126.1 123.6–128.7 .001‡
Basic 130.1 124.1–136.2 135.9 130.1–141.8 130.4 127.3–133.4 129.5 126.5–132.4 127.4 124.8–129.9 NS
Extended 3 133.0 130.7–135.3 130.1 127.8–132.3 129.6 128.4–130.7 128.5§ 127.4–129.6 129.1§ 128.1–130.0 .013‡
CES-D indicates Center for Epidemiologic Studies Depression Scale; cfPWV, carotid-femoral pulse wave velocity; HDL, high-density lipoprotein; LDL, low-density
lipoprotein; PP, pulse pressure; SBP, systolic blood pressure; WC, waist circumference; age-adjusted: adjusted for age; basic set: adjusted for age, education, sex,
and race; extended set 3: adjusted for variables in basic setheight, weight, heart rate, antihypertensive drug treatment, mean arterial pressure, WC, total cholesterol,
HDL and LDL cholesterol, CES-D raw scoregrains per day, vegetables per day, sweets per day, protein per day, and total food servings per day.
*P for overall omnibus outcome.
†P0.05 for statistically significant linear trend.
‡P 0.01 for statistically significant linear trend.
§Data were significantly different from the never/seldom group.
Data were significantly different from 1 time per wk group.
¶Data were significantly different from the 2–4 times per wk group.
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These findings are consistent with research examining the
effects of different milk-derived proteins on BP and arterial
stiffness. Peptides derived from milk protein, including caso-
kinins (casein derived) and lactokinins (whey derived) have
been shown to inhibit angiotensin I–converting enzyme
activity, an important enzyme involved in BP regulation.19,20
Beneficial effects on BP and augmentation index have been
reported for both fermented milk rich in casein21–23 and rich
in whey protein.24,25 A more recent study found that ionic
calcium, in addition to lactic acid bacteria, released during
milk fermentation also contributed to angiotensin I–convert-
ing enzyme–inhibitory activity.26 This small collection of
research does provide evidence for the role of probiotic dairy
products in BP modification. Further research is needed to
determine their role in the treatment of arterial stiffness.
Our data support one of the first intervention studies to
examine the effects of low-fat dairy product consumption on
BP, in addition to other risk parameters of the metabolic
syndrome.3 Consumption of 3 servings of low-fat dairy foods
in overweight individuals for 8 weeks resulted in a significant
reduction in SBP (2.97.4 mm Hg). The high dairy diet
showed no relationship with total cholesterol, LDL choles-
terol, or triglycerides.
Our findings also support studies that have examined dairy
products without added probiotics in relation to measures of
CVD. These include a number of recent reviews, including a
meta-analysis by Elwood et al,27 who found significant
reductions in the relative risk of ischemic heart disease,
ischemic stroke, and hemorrhagic stroke in those who con-
sume the most milk, and other reviews of prospective studies,
which have failed to find a consistent relationship between
dairy food intake and coronary heart disease.28,29 Most
recently, an increased consumption of yoghurt has been
associated with carotid artery intima-media thickness,30 a
marker of atherosclerotic vascular disease and predictor of
future cardiovascular and cerebrovascular events.31 This
study showed that women aged 70 years who consumed
100 g of yoghurt per day had a significantly lower carotid
artery intima-media thickness than those with lower yoghurt
intakes, after adjustment for baseline, dietary, and lifestyle
risk factors. Higher milk, cheese, or total dairy intakes were
not associated with carotid artery intima-media thickness or
with SBP or DBP. An earlier prospective study found that
yoghurt intake was associated with a lower risk of acute
myocardial infarction,32 a clinical consequence of atheroscle-
rotic vascular disease.
Little is known about the mechanisms by which dairy
foods may improve BP or arterial stiffening, a slow process
resulting from changes in the extracellular matrix of the
arterial walls. The strongest evidence surrounds the role of
bioactive peptides derived from dairy protein, released during
digestion, to inhibit angiotensin I–converting enzyme, mod-
ulate endothelial function, and cause vasodilatation.33 Addi-
tional components of dairy are likely to play a role. High
levels of potassium have been associated with lower BP in
numerous observational studies and clinical trials.34 Dietary
potassium is thought to cause vasodilatation by stimulating
the sodium pump and opening potassium channels, as well as
reducing vasoconstrictive sensitivity to angiotensin II.34 Mag-
nesium modulates vascular tone and reactivity and stimulates
the production of vasodilators, improving blood flow and
decreasing vascular resistance, thereby lowering BP and
increasing arterial function.35 Phosphorus from dairy prod-
ucts has been associated recently with lower BP and a
reduced risk of incident hypertension in a large prospective
study.36 Without a known mechanism on how dairy phospho-
rus may reduce BP, it may be the combination of a range of
nutrients in dairy foods that is effective in modulating BP.
Finally, dietary calcium has been linked with low BP,
working in combination with sodium, potassium, and mag-
nesium to ensure ionic balance, stabilize vascular cell mem-
branes, and increase vasodilatation.34 BP reduction may also
be mediated by body weight or fat reductions, because
substantial evidence exists for an antiobesity effect of
dairy,37–39 and any positive effect on weight loss will be of
benefit to BP.
Studies have reported that consumption of caffeinated tea
and coffee affects PWV if consumed immediately before
PWV analyses.40,41 Our participants consumed noncaffein-
ated tea and coffee on the day of the examination. Coffee and
tea consumption as a routine part of the diet was not related
to cfPWV, PP, or BP.
Although the differences in cfPWV and SBP according to
dairy food intake in this study were relatively small (differ-
ence of 1.0 m/s and 4.5 mm Hg between never/seldom and
5–6 times per week groups for cfPWV and SBP, respec-
tively), the differences are likely to be clinically significant.
In a recent meta-analysis, it was estimated that, for every
1 m/s increase in cfPWV, there were age-, sex,- and risk
factor–adjusted increases of 14%, 15%, and 15% in total
CVD events, CVD mortality, and all-cause mortality, respec-
tively.7 Clearly, hypertension represents a modifiable risk
factor with US data suggesting that even small reductions in
BP can have a great public health impact and translate into
substantial reductions in coronary heart disease and stroke
events.42,43 It has been estimated that a reduction in SBP by
2 mm Hg may reduce the risk for stroke and myocardial
infarction by 4%.44
A limitation to the study can be regarded as the lack of
detailed information regarding quantities of foods, including
dairy food, consumed. Participants were asked, “How often
do you eat the following foods?” but were not required to
estimate portion or serving sizes. Quantities are therefore
likely to differ substantially among individuals, as well as the
same individual on different occasions. In addition, the range
of responses to indicate how often a food is consumed was
limited in the high intake range; that is, there was not a more
specific measure of intake beyond “once or more a day.” We
are also unable to stipulate the fat content of dairy food
consumed based on information provided (with the exception
of milk). The study was cross-sectional, and dietary measure-
ment at only 1 point in time may not reflect long-term
consumption patterns. Secondly, the cross-sectional nature of
the study does not enable us to come to any conclusions
regarding causality. We are unable to infer that increasing
dairy intake may decrease arterial stiffness. The age range in
the present study was wide, but we adjusted for age in our
statistical analytic procedures, because we did not have
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sufficient numbers of subjects to examine results for multiple
age groups over a narrower range of ages. Finally, the MAP
in this study was estimated using SBP and DBP and was not
a true measure of MAP.
This study has a number of strengths. This is the first
cross-sectional study that has examined dairy food intake (not
limited to fermented dairy products) and cfPWV as a measure
of arterial stiffness. We have examined this relationship in a
large, community-dwelling, healthy sample across a wide age
span and controlled for relevant demographic, health, and
dietary variables.
Perspectives
Higher dairy food intake was associated with lower cfPWV
and accompanying reductions of PP and SBP. Further evi-
dence from long-term longitudinal or intervention studies is
needed before the incorporation of dairy foods into a bal-
anced diet for the attenuation of arterial stiffening can be
recommended. However, this initial analysis of dairy con-
sumption in relation to arterial stiffness indicates that dairy
consumption is not associated with a worsening of traditional
risk factors, such as hypercholesterolemia and hypertension,
and may indeed have benefits in reducing arterial stiffness.
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Figure S1. Relationship between dairy intake and pulse wave velocity (A), pulse pressure (B), 
and systolic blood pressure (C) for the extended model.
HYPERTENSION/2011/190017 R1 
 
Table S1.   Sample characteristics (N=587) and correlations between cfPWV and dairy 
intake, with health and nutrition data 
 
Variable Mean or % SD cfPWV r Total dairy r 
Age, y 63.8 12.4 0.53† 0.11† 
Education, y 14.6 2.8 -0.07 0.11* 
cfPWV, m/s 10.3 2.8  -0.08* 
Augmentation index 33.0 10.3 0.03 0.05 
MAP, mm Hg 94.7 12.1 0.32† -0.12† 
PP, mm Hg 52.1 15.6 0.58† -0.09* 
SBP, mm Hg 129.4 20.0 0.50† -0.12† 
DBP, mm Hg 77.3 10.0 0.08 -0.10* 
Heart rate, bpm 60.1 9.3 0.19† -0.04 
Height, cm 167.4 10.0 0.06 -0.15† 
Weight, kg 83.1 19.3 0.11† -0.11† 
BMI, kg/m2 29.6 6.5 0.09* -0.03 
WC, cm 93.9 15.7 0.27† -0.12† 
Total cholesterol, mmol/L 4.8 1.0 -0.10* 0.13† 
HDL, mmol/L 1.38 0.40 -0.13† 0.09* 
LDL, mmol/L 2.89 0.84 -0.11* 0.12† 
Glucose, mmol/L 5.44 1.28 0.26† -0.07 
Triglycerides, mmol/L 1.29 0.88 0.10* 0.02 
Plasma homocysteine, µmol/L 10.1 3.3 0.34† -0.07 
Physical activity, MET hrs/wk 22.5 27.3 -0.11* 0.07 
Cigarettes/wk 7.9 35.2 -0.01 -0.04 
Alcohol, g/wk 31.5 56.5 0.01 0.00 
Depression, CES-D raw score 8.0 7.5 -0.06 -0.09* 
Female, % 61.8  -0.16† 0.16† 
White, % 85.9  0.11† 0.24† 
CVD, % 11.9  0.28† -0.01 
Diabetes, % 14.8 0.29† -0.06 
Hypertension, % 61.3  0.39† -0.06 
Obese, % 38.5  0.11* -0.02 
Hypertension medication, % 54.0  0.35† -0.03 
Diabetes medication, % 13.5  0.27† -0.04 
Cholesterol medication, % 34.8  0.20† -0.07 
Depressed mood, % 12.9  -0.08* -0.02 
     
Nutrition data     
Grains/day 3.4 2.1 0.11† 0.06 
Fruit/day 1.6 1.1 0.10* 0.08 
Vegetables/day 2.7 1.2 -0.00 0.22† 
Protein foods/ day 1.8 0.8 0.02 0.23† 
Other (fats/sweets)/day 1.9 1.8 -0.08 -0.07 
Alcoholic drinks/day 0.4 0.7 -0.01 0.01 
Total all foods serves/day‡ 12.6 4.0 0.04 0.22† 
 
BMI indicates body mass index; CES-D, Centre for Epidemiologic Studies Depression Scale; 
cfPWV, carotid-femoral pulse wave velocity; CVD, cardiovascular disease; DBP, diastolic 
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blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MAP, mean 
arterial pressure; PP, pulse pressure; SBP, systolic blood pressure; WC, waist circumference. 
* P<0.05. 
† P<0.01. 
‡ includes dairy and alcohol. 
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Table S2.   Results of analysis of covariance, showing associations between cfPWV, BP, waist circumference, and blood lipids across 
increasing intakes of dairy food (N=587) 
 
Outcome 
measure 
Covariate set Dairy food intake P* 
  Never/ seldom  
n = 37 
1 time/ week 
n = 40 
2-4 times/ week 
n = 141 
5-6 times/ week 
n = 153 
≥1/day 
n = 216 
 
  Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI  
cfPWV Age-adjusted 10.8 10.0, 11.5 11.1 10.4, 11.8 10.8 10.4, 11.2 9.9¶ # 9.6, 10.3 10.0# 9.7, 10.3 .000‡ 
 Basic 10.6 9.8, 11.4 10.9 10.2, 11.6 10.7 10.3, 11.1 10.0 9.6,10.3 10.1 9.7, 10.4 .016† 
 Extended 1 10.9 10.2,11.6 10.6 9.9, 11.3 10.6 10.3, 11.0 10.0 9.7,10.3 10.1 9.8, 10.4 .021‡ 
 Extended 2 10.9 10.2,11.6 10.7 10.0, 11.4 10.6 10.3, 11.0 10.0 9.7,10.3 10.1 9.9, 10.4 .033† 
 Extended 3 11.0 10.3, 11.7 10.8 10.1, 11.5 10.6 10.3, 11.0 10.0 9.6,10.3 10.1 9.8, 10.4 .018‡ 
             
PP  Age-adjusted 56.3 51.9, 60.7 57.8 53.5, 62.1 53.2 50.9, 55.5 51.3 49.1, 53.4 50.2¶ 48.3, 52.0 .003‡ 
 Basic 56.3 51.9, 60.6 56.6 52.3, 60.9 52.7|| 50.5, 55.0 51.4|| 49.2, 53.5 50.6|| 48.8, 52.4 .035‡ 
 Extended 1 58.0 54.7, 61.3 54.1 50.9, 57.3 52.5|| 50.8, 54.2 50.6|| 49.0, 52.2 51.4|| 50.1, 50.8 .001§ 
 Extended 2 58.2 54.8, 61.5 53.4 50.1, 56.7 52.5|| 50.8, 54.2 50.7|| 49.1, 52.3 51.5|| 50.2, 52.9 .003§ 
 Extended 3 57.6 54.1, 61.0 53.1 49.8, 56.5 52.4 50.6, 54.1 50.8|| 49.2, 52.4 51.6|| 50.2, 53.0 .013‡ 
             
SBP Age-adjusted 131.8 125.6, 137.9 138.7 132.7, 144.6 131.7 128.5, 134.8 128.8¶ 125.8, 131.9 126.1¶ 123.6, 128.7 .001‡ 
 Basic 130.1 124.1, 136.2 135.9 130.1, 141.8 130.4 127.3, 133.4 129.5 126.5, 132.4 127.4 124.8, 129.9 NS 
 Extended 1 133.3 131.2, 135.5 130.7 128.6, 132.8 129.7|| 128.5, 130.8 128.4|| 127.3, 129.5 128.9|| 128.0, 129.8 .001§ 
 Extended 2 133.4 131.2, 135.7 130.3 128.1, 132.5 129.7|| 128.5, 130.8 128.5|| 127.4, 129.6 129.0|| 128.1, 129.9 .003§ 
 Extended 3 133.0 130.7, 135.3 130.1 127.8, 132.3 129.6 128.4, 130.7 128.5|| 127.4, 129.6 129.1|| 128.1, 130.0 .013‡ 
             
DBP†† Age-adjusted 75.5 72.3, 78.6 80.9 77.8, 83.9 78.5 76.8, 80.1 77.6 76.0, 79.1 76.0¶ 74.7, 77.3 .015 
 Basic 73.9 70.9, 76.9 79.3 76.4, 82.2 77.6 76.1, 79.1 78.1 76.6, 79.5 76.7 75.5, 78.0 NS 
 Extended 1 74.1 71.2, 77.1 78.8 75.9, 81.6 77.5 76.0, 79.0 78.2 76.8, 79.7 76.8 75.5, 78.0 NS 
 Extended 2 74.3 71.4, 77.2 78.4 75.5, 81.3 77.5 76.0, 79.0 78.2 76.8, 79.6 76.8 75.6, 78.0 NS 
 Extended 3 74.9 71.9, 77.9 78.3 75.3, 81.2 77.4 75.9, 78.9 78.2 76.8, 79.6 76.8 75.6, 78.1 NS 
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WC Age-adjusted 94.7 89.6, 99.7 97.3 92.3, 102.2 96.7 94.1, 99.3 93.0 90.5, 95.5 91.9# 89.8, 94.0 .034 
 Basic 91.8 87.1, 96.5 94.5 89.9, 99.1 95.2 92.8, 97.6 93.9 91.6, 96.2 93.2 91.3, 95.2 NS 
 Extended 1 95.4 93.2, 97.6 95.0 92.9, 97.2 94.2 93.1, 95.4 93.8 92.7, 94.9 93.8 92.3, 94.1 NS 
 Extended 2 95.6 93.4, 97.7 95.4 93.3, 97.6 94.1 93.0, 95.2 93.9 92.9, 94.9 93.3 92.5, 94.2 NS 
 Extended 3 96.0 93.8, 98.3 95.1 92.9, 97.3 93.8 92.7, 94.9 93.9 92.8, 94.9 93.3 92.4, 94.3 NS 
             
Total  Age-adjusted 4.5 4.2, 4.9 4.5 4.1, 4.8 4.8 4.6, 5.0 4.9 4.8, 5.1 4.9 4.8, 5.1 .017‡ 
cholesterol‡‡ Basic 4.7 4.4, 5.0 4.6 4.3, 4.9 4.9 4.7, 5.0 4.9 4.7, 5.0 4.9 4.7, 5.0 NS 
 Extended 1 4.7 4.4, 5.0 4.7 4.4, 4.9 4.8 4.7, 5.0 4.9 4.7, 5.0 4.9 4.7, 5.0 NS 
 Extended 2 4.7 4.4, 5.0 4.7 4.4, 5.0 4.9 4.7, 5.0 4.9 4.7, 5.0 4.9 4.7, 5.0 NS 
 Extended 3 4.7 4.4, 5.0 4.7 4.4, 5.0 4.9 4.7, 5.0 4.9 4.7, 5.0 4.8 4.7, 5.0 NS 
             
HDL- Age-adjusted 1.3 1.2, 1.4 1.4 1.3, 1.5 1.3 1.3, 1.4 1.4 1.3, 1.5 1.4 1.4, 1.5 NS 
cholesterol‡‡ Basic 1.4 1.3, 1.5 1.4 1.3, 1.6 1.4 1.3, 1.4 1.4 1.3, 1.4 1.4 1.3, 14 NS 
 Extended 1 1.4 1.2, 1.5 1.5 1.3, 1.6 1.4 1.3, 1.4 1.4 1.3, 1.4 1.4 1.3, 1.4 NS 
 Extended 2 1.4 1.3, 1.5 1.5 1.4, 1.6 1.4 1.3, 1.4 1.4 1.3, 1.4 1.4 1.3, 1.4 NS 
 Extended 3 1.4 1.3, 1.5 1.5 1.4, 1.6 1.4 1.3, 1.4 1.4 1.3, 1.4 1.4 1.3, 1.4 NS 
             
LDL- Age-adjusted 2.7 2.4, 3.0 2.5 2.3, 2.8 2.9 2.7, 3.0 3.0¶ 2.8, 3.1 2.9¶ 2.8, 3.1 .013‡ 
cholesterol‡‡ Basic 2.8 2.5, 3.1 2.6 2.4, 2.9 2.9 2.8, 3.0 2.9 2.8, 3.1 2.9 2.8, 3.0 NS 
 Extended 1 2.8 2.5, 3.1 2.7 2.4, 2.9 2.9 2.7, 3.0 3.0 2.8, 3.1 2.9 2.8, 3.0 NS 
 Extended 2 2.8 2.5, 3.1 2.7 2.4, 2.9 2.9 2.7, 3.0 3.0 2.8, 3.1 2.9 2.8, 3.0 NS 
 Extended 3 2.8 2.5, 3.1 2.7 2.4, 3.0 2.9 2.8, 3.0 3.0 2.8, 3.1 2.9 2.8, 3.0 NS 
             
Triglycerides Age-adjusted 1.2 0.9, 1.5 1.2 0.9, 1.5 1.3 1.2, 1.5 1.3 1.1, 1.4 1.3 1.2, 1.4 NS 
 Basic 1.2 0.9, 1.5 1.2 1.0, 1.5 1.3 1.2, 1.5 1.3 1.1, 1.4 1.3 1.2, 1.4 NS 
 Extended 1 1.3 1.0, 1.5 1.2 0.9, 1.5 1.3 1.2, 1.4 1.3 1.1, 1.4 1.3 1.2, 1.4 NS 
 Extended 2 1.2 1.2, 1.3 1.3 1.2, 1.3 1.2 1.2, 1.3 1.2 1.2, 1.3 1.2 1.2, 1.3 NS 
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 Extended 3 1.2 1.2, 1.3 1.3 1.2, 1.3 1.2 1.2, 1.3 1.2 1.2, 1.3 1.2 1.2, 1.3 NS 
 
CES-D indicates Centre for Epidemiologic Studies Depression Scale; cfPWV, carotid-femoral pulse wave velocity; DBP, diastolic blood 
pressure; HDL, high density lipoprotein; LDL, low density lipoprotein; SBP, systolic blood pressure; WC, waist circumference. 
 
Age-adjusted set: adjusted for age. 
Basic set: adjusted for age, education, gender, race. 
Extended set 1: adjusted for variables in basic set + height, weight, heart rate, antihypertensive drug treatment, mean arterial pressure. 
Extended set 2: adjusted for variables in extended set 1 + WC, total cholesterol, HDL- and LDL-cholesterol. 
Extended set 3: adjusted for variables in extended set 2 + CES-D raw score + grains/day, vegetables/day, sweets/day, protein/day, total food 
serves/day. 
 
*P for overall omnibus outcome. 
†p <0.05, ‡p <0.01, § p < 0.001, for statistically significant linear trend. 
|| significantly different from the never/seldom group. 
¶  significantly different from the 1 time/week group. 
# significantly different from the 2-4 times/week group. 
†† not adjusted for mean arterial pressure. 
‡‡ not adjusted for total, LDL- or HDL-cholesterol. 
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Figure Legends 
 
Figure S1. Relationship between dairy intake and pulse wave velocity (A), pulse pressure 
(B), and systolic blood pressure (C) for the extended model 
 
 
